Explore
PET/CT Imaging in Oncology: Clinical Updates and Perspectives
0 Ungluers have
Faved this Work
Login to Fave
This reprint focuses on the most recent advances in PET/CT imaging within the field of oncology. These innovations include studies on novel or experimental tracers, such as [18F]FES for the imaging of advanced breast cancer and [68Ga]Ga-Nitroimidazole for visualizing hypoxic tumour components; research on new radiopharmaceuticals represents, in fact, one the most important study fields of PET research. Advanced image analysis, such as radiomics, is also featured in this reprint; this method has been applied to both traditional nuclear medicine clinical issues, such as thyroid nodules, as well as in the setting of new therapeutic approaches, such as CAR-T cell therapy. Finally, the theranostic implications of PET radiotracers and the diagnostic processes of rare tumours are explored in this reprint.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 18 times via unglue.it ebook links.
- 18 - pdf (CC BY) at Unglue.it.
Keywords
- 18F-FDG
- 68Ga-Nitroimidazole
- Breast cancer
- cervical cancer
- cervical carcinoma
- chimeric antigen receptor T cells
- Computed Tomography
- Diagnosis
- diffuse-large B cell lymphoma
- dual-time-point kinetic
- Dynamic PET
- FDG
- FDG-PET
- Fès
- FGFR2 translocation
- fluorocholine
- fluorodeoxyglucose
- hemangiopericytoma
- HIF-1α
- Hodgkin lymphoma
- hypoxia
- imaging fusion
- immunohistochemistry
- immunology
- Immunotherapy
- intra-tumoural heterogeneity
- intrahepatic cholangiocarcinoma
- lymph node metastases
- Lyric
- mantle cell lymphoma
- medicine
- meningioma
- MTV
- multiparametric imaging
- n/a
- navigation technology
- neurooncology
- non-FDG radiopharmaceuticals
- nuclear medicine
- oestrogen receptor
- parametric FDG
- paraneoplastic syndromes
- Patlak
- peptide receptor radionuclide therapy
- PET/CT
- PNS
- positron emission tomography
- positron emission tomography–computed tomography
- prostate carcinoma
- PRRT
- pseudoprogression
- PSMA hybrid imaging
- radiomics
- response assessment
- Sarcopenia
- solitary fibrous tumor
- somatostatin receptor
- SSTR
- staging of primary prostate cancer
- SUVmax cut-off level
- targeted therapy
- texture analysis
- Thyroid cancer
- thyroid incidentalomas
- TLG
- whole-body
- [18F]FDG PET/CT
- [18F]FDG PET/MRI
- [18F]PSMA-1007
- [68Ga]Ga-PSMA-11
Links
DOI: 10.3390/books978-3-0365-9451-4Editions